Stoke Therapeutics Inc buy Canaccord Genuity Group Inc.
Start price
28.04.23
/
50%
€8.85
Target price
28.04.24
€21.78
Performance (%)
28.81%
End price
29.04.24
€11.40
Summary
This prediction ended on 29.04.24 with a price of €11.40. The prediction had a final performance of 28.81%. Canaccord_Genuity_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Stoke Therapeutics Inc | -9.353% | -9.353% | 186.364% |
| iShares Core DAX® | 2.331% | 5.140% | 25.000% |
| iShares Nasdaq 100 | 2.077% | 2.956% | 8.935% |
| iShares Nikkei 225® | 2.759% | 7.214% | 22.171% |
| iShares S&P 500 | 1.613% | 2.893% | 6.249% |
Comments by Canaccord_Genuity_Gr for this prediction
In the thread Stoke Therapeutics Inc diskutieren
Stoke Therapeutics, Inc. (NASDAQ: STOK) is now covered by analysts at Canaccord Genuity Group Inc.. They set a "buy" rating and a $24.00 price target on the stock.
Ratings data for STOK provided by MarketBeat
In the thread Trading Stoke Therapeutics Inc
Die von Canaccord_Genuity_Gr gewählte maximale Laufzeit wurde überschritten